等待開盤 07-07 09:30:00 美东时间
+0.060
+0.31%
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. Monday - July 6 Vo...
07-04 03:00
Shares of AeroVironment, Inc. (NASDAQ:AVAV) rose sharply in pre-market trading after the company reported better-than-expected financial results for the fourth quarter of fiscal 2026. AeroVironment guided for fiscal 2027 revenue of approximately $2.13 billion to $2.23 billion, versus estimates of $2...
06-30 18:10
生物制药公司Nuvectis Pharma(股票代码:NVCT)完成500万股稀释性二次公开发行定价,发行价为每股20.00美元,较前一交易日28.53美元的收...
06-30 16:26
纽维蒂斯制药(纳斯达克代码:NVCT)敲定1亿美元普通股公开发行定价,合计发售500万股普通股,每股定价20美元,预计总募资1亿美元,发行预计2026年7月1日...
06-30 12:51
Nuvectis Pharma (NVCT) had priced its underwritten public offering of 5M shares of its common stock at $20 per share, with expected gross proceeds of $100M, the company said Monday, sending shares dow...
06-30 12:09
生物医药公司Nuvectis Pharma(股票代码:NVCT)宣布启动由承销商担保的普通股公开发行,全部发行股份由公司自行发售。 关键条款与资金用途: 拟授...
06-30 10:35
Nuvectis Pharma prices 5 million-share offering at $20, raising $100 million Nuvectis priced an underwritten public offering of 5,000,000 common shares at USD 20 per share. Gross proceeds expected at USD 100 million; closing targeted for about July 1, 2026. Underwriters hold a 30-day option to buy u
06-30 10:30
临床阶段生物制药企业Nuvectis Pharma Inc(纳斯达克代码:NVCT)宣布启动普通股承销公开发行后,该股周一盘后交易时段下跌20.5%。 本次发行...
06-30 04:23
Nuvectis Pharma (NVCT) announced on Monday that it has launched an underwritten public offering of its common stock. The underwriters will have a 30-day option to purchase up to an additional 15% of t...
06-30 04:10
临床阶段生物制药公司Nuvectis Pharma, Inc.(纳斯达克股票代码:NVCT)宣布启动其普通股承销公开发行,全部股份由公司发售,同时拟授予承销商...
06-30 04:04